We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$6.99B
AUM Growth
+$1.23B
Cap. Flow
-$140M
Cap. Flow %
-2%
Top 10 Hldgs %
22.95%
Holding
1,634
New
85
Increased
643
Reduced
463
Closed
238

Top Buys

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$21.6M
2
GDS icon
GDS Holdings
GDS
+$16.6M
3
DELL icon
Dell
DELL
+$12.3M
4
PARA
Paramount Global Class B
PARA
+$12M
5
LUMN icon
Lumen
LUMN
+$11M

Sector Composition

Rank Sector Weight
1 Real Estate 16.24%
2 Technology 13.67%
3 Consumer Discretionary 10.4%
4 Healthcare 8.54%
5 Communication Services 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLF icon
1301
Herbalife
HLF
$1.23B
-20,967
Closed -$930K
HRTX icon
1302
Heron Therapeutics
HRTX
$86.3M
-4,604
Closed -$75K
IBRX icon
1303
ImmunityBio
IBRX
$7.44B
-1,618
Closed -$38K
ICOW icon
1304
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
$1.76B
-9,764
Closed -$305K
IDCC icon
1305
InterDigital
IDCC
$6.68B
-3,571
Closed -$227K
IEMG icon
1306
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
-1,185
Closed -$76K
IGMS
1307
DELISTED
IGM Biosciences
IGMS
-890
Closed -$68K
IMVT icon
1308
Immunovant
IMVT
$8.09B
-4,594
Closed -$74K
INO icon
1309
Inovio Pharmaceuticals
INO
$79.8M
-619
Closed -$69K
INSM icon
1310
Insmed
INSM
$23.2B
-1,990
Closed -$68K
IONS icon
1311
Ionis Pharmaceuticals
IONS
$9.35B
-1,471
Closed -$66K
IOVA icon
1312
Iovance Biotherapeutics
IOVA
$2.23B
-2,187
Closed -$69K
IRWD icon
1313
Ironwood Pharmaceuticals
IRWD
$611M
-6,889
Closed -$77K
ITOS
1314
DELISTED
iTeos Therapeutics
ITOS
-640
Closed -$22K
KALV
1315
DELISTED
KalVista Pharmaceuticals
KALV
-430
Closed -$11K
KNSA icon
1316
Kiniksa Pharmaceuticals
KNSA
$4.83B
-1,503
Closed -$28K
KOD icon
1317
Kodiak Sciences
KOD
$2.59B
-613
Closed -$70K
KPTI icon
1318
Karyopharm Therapeutics
KPTI
$168M
-422
Closed -$67K
KROS icon
1319
Keros Therapeutics
KROS
$199M
-790
Closed -$49K
KRRO icon
1320
Korro Bio
KRRO
$153M
-29
Closed -$14K
KRYS icon
1321
Krystal Biotech
KRYS
$9.88B
-602
Closed -$46K
KSA icon
1322
iShares MSCI Saudi Arabia ETF
KSA
$647M
-573
Closed -$21K
KURA icon
1323
Kura Oncology
KURA
$922M
-2,618
Closed -$74K
KYMR icon
1324
Kymera Therapeutics
KYMR
$9.1B
-1,208
Closed -$47K
MCRB icon
1325
Seres Therapeutics
MCRB
$48M
-182
Closed -$75K

Similar funds

Pacer Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Pacer Advisors held 1,634 positions worth $6.99B, up 21% from $5.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Pacer Advisors's Q2 2021 filing shows 85 new, 643 increased, 463 reduced and 238 closed positions. Its largest new stake was DigitalBridge: 754,679 shares worth $23.8M. The largest sale was Crown Castle, an estimated $11.5M.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Pacer Advisors's largest Q2 2021 buy was DigitalBridge: 754,679 shares worth $23.8M.
  • Pacer Advisors added most to GDS Holdings in Q2 2021, an estimated $16.6M increase.
  • Pacer Advisors's biggest Q2 2021 reduction was Crown Castle, cutting an estimated $11.5M.
  • Pacer Advisors fully exited Pacer Trendpilot US Mid Cap ETF in Q2 2021, selling an estimated $8.38M.
  • Pacer Advisors's ten largest holdings make up 23% of its $6.99B portfolio in Q2 2021.
  • Pacer Advisors opened 85 new positions and closed 238 in Q2 2021.
  • Pacer Advisors's portfolio value rose 21% quarter-over-quarter to $6.99B.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.